About REVO Oncology
REVO Oncology is a private company based in Frisco, Texas, incorporated in 2025 in Delaware. It has reported $270,000 raised in one offering on Form D since April 2026. Its chief executive is Estevan Kiernan.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Sep 17, 2025 | Apr 13, 2026 | $270,000of $1.2M target | 7 | $38,571 | Simple Agreement for Future EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on REVO Oncology's Form D filed Apr 13, 2026.
EK
Estevan Kiernan
President and Chief Executive Officer, director